Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2310-2314

  Ahmadi, Naser ^a,b   Nabavi, Vahid ^a   Hajsadeghi, Fereshteh ^a   Zeb, Irfan ^a   Flores, Ferdinand ^a   Ebrahimi, Ramin ^b   Budoff, Matthew ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aged garlic extract; Coronary artery calcium; Vascular function; White epicardial adipose tissue

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; CYANOCOBALAMIN; FOLIC ACID; GARLIC EXTRACT; HOMOCYSTEINE; KYLOIC 108; PLACEBO; PYRIDOXINE; UNCLASSIFIED DRUG; PLANT EXTRACT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BROWN ADIPOSE TISSUE; BROWN EPICARDIAL ADIPOSE TISSUE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH EDUCATION; HEART PROTECTION; HUMAN; HUMAN TISSUE; HYPEREMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TEMPERATURE; TREATMENT DURATION; VASCULAR DISEASE; WHITE ADIPOSE TISSUE; WHITE EPICARDIAL ADIPOSE TISSUE; ATHEROSCLEROSIS; BLOOD; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIET SUPPLEMENTATION; DOSE RESPONSE; GARLIC; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERICARDIUM; RISK FACTOR; THERMOMETRY; TIME; TREATMENT OUTCOME;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADULT; AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GARLIC; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PLANT EXTRACTS; RISK FACTORS; THERMOMETRY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84885642025     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.182     Document Type: Article

References (44)

1. P. Young, J.R. Arch, and M. Ashwell Brown adipose tissue in the parametrial fat pad of the mouse FEBS Lett 167 1984 10 14
2. C. Tiraby, and D. Langin Conversion from white to brown adipocytes: a strategy for the control of fat mass? Trends Endocrinol Metab 14 2003 439 441
3. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 2006 772 783
4. S. Gesta, Y.H. Tseng, and C.R. Kahn Developmental origin of fat: tracking obesity to its source Cell 131 2007 242 256
5. B. Cannon, and J. Nedergaard Brown adipose tissue: function and physiological significance Physiol Rev 84 2004 277 359
6. S.R. Farmer Molecular determinants of brown adipocyte formation and function Genes Dev 22 2008 1269 1275
7. J.W. Jeong, M.H. Jeong, and K.H. Yun Echocardiographic epicardial fat thickness and coronary artery disease Circ J 71 2007 536 539
8. P. Maurovich-Horvat, J. Massaro, C.S. Fox, F. Moselewski, C.J. O'Donnell, and U. Hoffmann Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography Int J Obes (Lond) 31 2007 500 506
9. G. Iacobellis, and G. Barbaro The double role of epicardial adipose tissue as pro- and anti-inflammatory organ Horm Metab Res 40 2008 442 445
10. J.N. Fain, A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282
11. R. Taguchi, J. Takasu, and Y. Itani Pericardial fat accumulation in men as a risk factor for coronary artery disease Atherosclerosis 157 2001 203 209
12. N.H.F. Ahmadi, M. Budoff, G. Brent, and R. Ebrahimi Accurate detection of metabolically active "brown" adipose tissue with computed tomography J Am Coll Cardiol 59 13s1 2012 E1343
13. M.J. Budoff, N. Ahmadi, and K.M. Gul Aged garlic extract supplemented with B vitamins, folic acid and l-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial Prev Med 49 2009 101 107
14. N. Ahmadi, S. Tsimikas, and F. Hajsadeghi Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium Am J Cardiol 105 2010 459 466
15. S. Tsimikas In vivo markers of oxidative stress and therapeutic interventions Am J Cardiol 101 2008 34D 42D
16. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
17. P. Raggi, T.Q. Callister, and L.J. Shaw Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy Arterioscler Thromb Vasc Biol 24 2004 1272 1277
18. N. Ahmadi, V. Nabavi, and E. Yang Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium Acad Radiol 17 2010 1518 1524
19. S. Tsimikas, M. Aikawa, F.J. Miller Jr, E.R. Miller, M. Torzewski, S.R. Lentz, C. Bergmark, D.D. Heistad, P. Libby, and J.L. Witztum Increased plasma oxidized phospholipid: apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression Arterioscler Thromb Vasc Biol 27 2007 175 181
20. J. Ding, F.C. Hsu, and T.B. Harris The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA) Am J Clin Nutr 90 2009 499 504
21. S. Kiechl, J. Willeit, and M. Mayr Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study Arterioscler Thromb Vasc Biol 27 2007 1788 1795
22. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
23. J. Kopecky, G. Clarke, S. Enerback, B. Spiegelman, and L.P. Kozak Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity J Clin Invest 96 1995 2914 2923
24. M. Ghorbani, and J. Himms-Hagen Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats Int J Obes Relat Metab Disord 21 1997 465 475
25. J.G. Granneman, P. Li, Z. Zhu, and Y. Lu Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adrenergic receptor activation Am J Physiol Endocrinol Metab 289 2005 E608 E616
26. J. Himms-Hagen, A. Melnyk, M.C. Zingaretti, E. Ceresi, G. Barbatelli, and S. Cinti Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes Am J Physiol Cell Physiol 279 2000 C670 C681
27. D. Loncar Convertible adipose tissue in mice Cell Tissue Res 266 1991 149 161
28. D. Larrouy, H. Vidal, F. Andreelli, M. Laville, and D. Langin Cloning and mRNA tissue distribution of human PPARgamma coactivator-1 Int J Obes Relat Metab Disord 23 1999 1327 1332
29. A. Mazzucotelli, N. Viguerie, and C. Tiraby The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes Diabetes 56 2007 2467 2475
30. C. Tiraby, G. Tavernier, and C. Lefort Acquirement of brown fat cell features by human white adipocytes J Biol Chem 278 2003 33370 33376
31. R.L. Ryall, and R.B. Goldrick Glycerokinase in human adipose tissue Lipids 12 1977 272 277
32. P. Li, Z. Zhu, Y. Lu, and J.G. Granneman Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha Am J Physiol Endocrinol Metab 289 2005 E617 E626
33. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke, and D.M. Herrington Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397
34. C. Kirma, M. Akcakoyun, and A.M. Esen Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease Circ J 71 2007 698 702
35. A.A. Quyyumi Prognostic value of endothelial function Am J Cardiol 91 2003 19H 24H
36. J.P. Halcox, W.H. Schenke, and G. Zalos Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
37. C.T. Minson, and B.J. Wong Reactive hyperemia as a test of endothelial or microvascular function? J Am Coll Cardiol 43 2004 2147 [author reply - 8]
38. C. Binggeli, L.E. Spieker, and R. Corti Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol 42 2003 71 77
39. A.E. Fraley, G.G. Schwartz, and A.G. Olsson Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) trial J Am Coll Cardiol 53 2009 2186 2196
40. F.M. Fisher, S. Kleiner, and N. Douris FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis Genes Dev 26 2012 271 281
41. Y. Li, C. Jiang, and G. Xu Homocysteine upregulates resistin production from adipocytes in vivo and in vitro Diabetes 57 2008 817 827
42. Z. Chen, C.S. Li, J. Zhang, B.S. Pang, C.Q. Xia, and X.F. Liu Relationship between endothelial dysfunction and serum homocysteine in patients with coronary lesions Chin Med Sci J 20 2005 63 66
43. C. Held, G. Sumner, and P. Sheridan Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART) Vasc Med 13 2008 245 253
44. K.S. McCully Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases Ann Clin Lab Sci 41 2011 301 314